RCM Strategies to Explore for Genetic Testing Compliance
Expert Ashley Zarling details nuances for clinical lab directors and compliance teams
Reimbursement-nir
Subscribe today for access to
Articles and Reports
Recent MD Labs Ruling Has Implications for Test Requisitions and Commissions
A federal appeals court upheld the idea that clinical laboratories can rely on physician orders to justify medical necessity
OIG Report on Lab Testing Should Prompt Compliance Review
Genetic testing now accounts for 43 percent of all Medicare Part B laboratory spending
COVID-19 Testing Drives Increase in Part B Medicare Lab Spending
Here’s a look at the key takeaways from the Dec. 30 OIG report on Medicare Part B spending on lab testing.
CMS Recognizes 3 New CLIA-Waived (CW) Tests
...
Already a member? Log in here
Congress Acts to Delay 2022 PAMA Price Cuts at the Eleventh Hour
...
Already a member? Log in here
Medicare Reimbursement: The 5 Things Labs Need to Know about the 2022 Physician Fee Schedule
...
Already a member? Log in here
The 4 Things Labs Need to Know About the 2022 OPPS Payments Rule
...
Already a member? Log in here
OIG Calls on CMS to Recover Phlebotomy Travel Allowance Overpayments
...
Already a member? Log in here
Biden Pulls Plug on Automatic Medicare Coverage for MCIT “Breakthrough” Devices
...
Already a member? Log in here
CMS Clarifies IDTF Billing, Coding and Coverage Rules
...
Already a member? Log in here
Medicare to Reimburse 6 New CLIA-Waived Tests, Starting Oct. 1
...
Already a member? Log in here
The Biden Budget: The 9 Things Lab Managers Should Know
...
Already a member? Log in here